Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450384 · ClinicalTrials.gov registry record · Phase 1
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
A Phase 1 study of Unspecified Adult Solid Tumor, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT01450384 is a Phase 1 study of Unspecified Adult Solid Tumor that has completed, run by Virginia Commonwealth University. The registered enrollment target is 37 participants, above the 33-participant average among 3 other Unspecified Adult Solid Tumor trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01450384, a Phase 1 study of Unspecified Adult Solid Tumor, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial studies the side effects and best dose of giving pemetrexed disodium and sorafenib tosylate together in treating patients with advanced solid tumors. Pemetrexed disodium and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Sorafenib tosylate may also stop the growth of solid tumors by blocking blood flow to the tumor. Giving pemetrexed disodium together with sorafenib tosylate may kill more tumor cells.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE biopsy
- DRUG pemetrexed disodium
- DRUG sorafenib tosylate
Study Locations (1)
Virginia
- Virginia Commonwealth University/Massey Cancer Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01450384
The ClinicalTrials.gov registry entry for NCT01450384 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 33-participant average among 3 other Unspecified Adult Solid Tumor trials with a reported enrollment target (12% higher). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unspecified Adult Solid Tumor appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01450384 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT01450384 about?
NCT01450384 is a clinical study titled "Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors". This phase I trial studies the side effects and best dose of giving pemetrexed disodium and sorafenib tosylate together in treating patients with advanced solid tumors. Pemetrexed disodium and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growt...
What is the current status of trial NCT01450384?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2011-10. Estimated completion is 2015-09.
What conditions does trial NCT01450384 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor.
What interventions are being tested in trial NCT01450384?
The interventions under investigation include: laboratory biomarker analysis (OTHER), biopsy (PROCEDURE), pemetrexed disodium (DRUG), sorafenib tosylate (DRUG).
Who is sponsoring clinical trial NCT01450384?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01450384 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
ACTIVE NOT RECRUITING · Phase 1
-
Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
COMPLETED · Phase 1
-
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.